Literature DB >> 20645810

Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

Daniela Fernandes Ramos1, Pedro Eduardo Almeida da Silva.   

Abstract

Tuberculosis remains a serious public health problem, with nine million cases being reported annually. Treatment with antibiotics is the most effective mechanism to control this disease, although the increase in cases with resistant strains, co-infection with HIV, and the long duration of treatment has established the need to develop new drugs. Here we show the activity of usnic acid against susceptible and resistant Mycobacterium tuberculosis strains and against nontuberculous mycobacteria. Further, we did not identify any contribution of efflux in innate resistance to usnic acid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645810     DOI: 10.3109/13880200903085490

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

1.  Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.

Authors:  Ina L Lauinger; Livia Vivas; Remo Perozzo; Christopher Stairiker; Alice Tarun; Mire Zloh; Xujie Zhang; Hua Xu; Peter J Tonge; Scott G Franzblau; Duc-Hung Pham; Camila V Esguerra; Alexander D Crawford; Louis Maes; Deniz Tasdemir
Journal:  J Nat Prod       Date:  2013-06-19       Impact factor: 4.050

2.  Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection.

Authors:  A A Shtro; V V Zarubaev; O A Luzina; D N Sokolov; N F Salakhutdinov
Journal:  Antivir Chem Chemother       Date:  2016-03-27

3.  Design, synthesis and antimicrobial activity of usnic acid derivatives.

Authors:  Kartsev Victor; Lichitsky Boris; Geronikaki Athina; Petrou Anthi; Smiljkovic Marija; Kostic Marina; Radanovic Oliver; Soković Marina
Journal:  Medchemcomm       Date:  2018-04-11       Impact factor: 3.597

4.  Usnic Acid Treatment Changes the Composition of Mycobacterium tuberculosis Cell Envelope and Alters Bacterial Redox Status.

Authors:  Elwira Sieniawska; Rafal Sawicki; Wieslaw Truszkiewicz; Andrey S Marchev; Milen I Georgiev
Journal:  mSystems       Date:  2021-05-04       Impact factor: 6.496

5.  Water soluble usnic acid-polyacrylamide complexes with enhanced antimicrobial activity against Staphylococcus epidermidis.

Authors:  Iolanda Francolini; Vincenzo Taresco; Fernanda Crisante; Andrea Martinelli; Lucio D'Ilario; Antonella Piozzi
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

6.  Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates.

Authors:  Rafaela S Ferraz-Carvalho; Marcela A Pereira; Leonardo A Linhares; Mariane Cb Lira-Nogueira; Isabella Mf Cavalcanti; Nereide S Santos-Magalhães; Lílian Ml Montenegro
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04-29       Impact factor: 2.743

Review 7.  Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.

Authors:  Laura Rindi
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.